Cargando…
Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
Background: For non-dialysis patients with hyperlipidemia, statins may provide clinical benefits in reducing mortality risk; however, the optimal treatment for dialysis patients with hyperlipidemia remains debatable. We evaluated the mortality risks for hyperlipidemic patients with renal disorders a...
Autores principales: | Sung, Fung-Chang, Jong, Ying-Chin, Muo, Chih-Hsin, Hsu, Chih-Cheng, Tsai, Wen-Chen, Hsu, Yueh-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930832/ https://www.ncbi.nlm.nih.gov/pubmed/35308209 http://dx.doi.org/10.3389/fphar.2022.815882 |
Ejemplares similares
-
Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study
por: Sung, Fung-Chang, et al.
Publicado: (2022) -
Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan
por: Hsu, Yueh-Han, et al.
Publicado: (2015) -
Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case–control study
por: Tsai, Wen-Hsuan, et al.
Publicado: (2023) -
Prescription of Radix Salvia miltiorrhiza in Taiwan: A Population-Based Study Using the National Health Insurance Research Database
por: Tseng, Ying-Jung, et al.
Publicado: (2021) -
Long-Term Use of Statins Lowering the Risk of Rehospitalization Caused by Ischemic Stroke Among Middle-Aged Hyperlipidemic Patients: A Population-Based Study
por: Yin, Jiu-Haw, et al.
Publicado: (2021)